Trial
NCT06181227
A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Aviceda Therapeutics, Inc.
Collaborators
—
Condition
Diabetic Macular Edema
Intervention
AVD-104
Why stopped
The trial was stopped early due to insufficient study drug supply and study funding constraints
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-14